Topic:

March 2023

Investments to Support Access to Drugs for Rare Diseases

On March 22, 2023 the Government announced a total investment of up to $1.5 billion over three years in support of the first-ever National Strategy for Drugs for Rare Diseases to help increase access to, and affordability of, promising and effective drugs for rare diseases to improve the health of patients across Canada. For more information, please visit https://www.canada.ca/en/health-canada/news/2023/03/investments-to-support-access-to-drugs-for-rare-diseases.html

Lupus Blog Articles:

Anifrolumab Now Covered Under BC PharmaCare for Lupus Treatment

Read

Belimumab for Lupus Nephritis in BC Now Approved Under BC Renal Formulary

Read

Lupus Treatment and Access Across Provinces: Take the Patient Survey

Read